The global cardiology EHR market is valued at USD 3.52 billion in 2026 and is expected to reach USD 5.44 billion by 2035, growing at a 4.95% CAGR. North America leads the market while Asia Pacific shows the fastest growth. Web/cloud-based EHR systems dominate the product segment, with ambulatory surgery centers expected to grow fastest by end-use category.

The global tele-monitoring services market is valued at USD 36.59 billion in 2026 and is expected to reach USD 164.55 billion by 2035, growing at an 18.18% CAGR. North America leads the market while Asia Pacific shows the fastest growth. Remote patient monitoring dominates by service type, with wearables and mobile devices driving device segment growth. Key drivers include rising chronic disease prevalence, aging populations, and technological advancements in IoT and AI.

The global clinical analytics market is experiencing rapid expansion driven by widespread EHR adoption, AI/ML advancements, and real-world evidence acceptance. The market is projected to grow at a 19.7% CAGR from $33.09 billion in 2025 to $81.32 billion by 2030, with Asia-Pacific leading regional growth. Key drivers include digital health adoption, value-based care transition, and precision medicine demand.

GE Medical Holding AB has exercised all 26,973,169 warrants in EXACT Therapeutics, generating NOK 33 million in gross proceeds. The warrant exercise was triggered by a positive safety read-out from the phase 2 ENACT trial in pancreatic cancer, which also showed early tumor shrinkage and significant biomarker reduction (>85% CA 19-9 decrease). Other warrant holders have until February 26, 2026 to exercise their warrants.

GE HealthCare reported Q4 adjusted earnings of $1.44 per share, beating consensus of $1.40, with sales of $5.69 billion exceeding expectations. The company achieved 7.1% revenue growth driven by strong performance in Pharmaceutical Diagnostics, Imaging, and Advanced Visualization Solutions. However, net income margin declined 320 basis points and adjusted EBIT margin fell 200 basis points due to tariff expenses and unfavorable mix. For 2026, GE HealthCare forecasts adjusted earnings of $4.95-$5.15 per share and expects lower tariff impacts than 2025.

The global telecardiology market is projected to grow from USD 12.42 billion in 2025 to USD 43.08 billion by 2033, with a CAGR of 16.84%. Growth is driven by technological advancements including AI-powered diagnostics, increased adoption post-COVID-19, and rising cardiovascular disease prevalence. The U.S. market is expected to reach USD 13.60 billion by 2033, while Asia Pacific emerges as the fastest-growing region.

The global medical equipment maintenance market is valued at USD 55.92 billion in 2026 and is projected to reach USD 121.94 billion by 2034, growing at a 10.04% CAGR. North America leads the market, while Asia Pacific shows the fastest growth. Imaging equipment dominates by equipment type, with surgical instruments expected to grow fastest. Preventive maintenance and third-party service providers are emerging as key growth segments.

The global Radiology AI market is projected to grow from USD 0.78 billion in 2025 to USD 7.09 billion by 2035, expanding at a CAGR of 24.80%. Growth is driven by rising chronic disease prevalence, increasing healthcare investments in AI and advanced imaging equipment, and the need for faster diagnostic accuracy. Diagnostic imaging and interpretation leads with 35% market share, while screening and triage is the fastest-growing segment at 28%.

The global mechanical ventilators market is projected to grow from USD 4.04 billion in 2025 to USD 6.91 billion by 2035, expanding at a CAGR of 5.53%. Growth is driven by rising respiratory disease prevalence, expanding ICU infrastructure, and technological advancements including AI-enabled and portable ventilators. However, high device costs and limited healthcare funding remain significant market constraints.

The global breast cancer imaging market is expected to grow at a CAGR of 7.7% from 2025 to 2033, driven by rising breast cancer incidence, technological advancements in imaging modalities like tomosynthesis and CESM, and increased government healthcare initiatives for early detection and screening.

The global radiochromic film market is projected to grow from USD 144.83 million in 2025 to USD 217.82 million by 2032, at a CAGR of 6.00%. Growth is driven by increasing demand in precision dosimetry, particle therapy, industrial inspections, and precision medicine. Key advancements include self-developing chemistry, high spatial resolution, and integration with digital quality assurance systems and automated workflows.

AI-driven clinical intelligence is transforming medical imaging, with point-of-care diagnostics projected to reach $70.92 billion by 2032. The CMS ACCESS Model launching in July 2026 will reward outcome-based care, driving adoption of software-defined imaging platforms. Key players including VentriPoint Diagnostics, Butterfly Network, Hyperfine, Hologic, and GE HealthCare are advancing portable, AI-powered diagnostic solutions that deliver hospital-grade precision at the bedside, reducing facility overhead while improving patient outcomes.